4//SEC Filing
CHEUNG ANTHONY TZEYEW 4
Accession 0000929638-24-001069
CIK 0001980845other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:42 PM ET
Size
6.7 KB
Accession
0000929638-24-001069
Insider Transaction Report
Form 4
CHEUNG ANTHONY TZEYEW
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-03-18−52,940→ 0 totalExercise: $0.89→ Common Shares (52,940 underlying) - Exercise/Conversion
Common Shares
2024-03-18$0.89/sh+52,940$47,117→ 102,873 total
Footnotes (2)
- [F1]This option is fully vested and exercisable.
- [F2]This option was originally due to expire December 4, 2023, however prior to that date the expiration date was extended to 120 days following the filing of enGene Holdings Inc.'s Form S-8, which was filed February 27, 2024. Accordingly, the option expiry date is June 26, 2024.
Documents
Issuer
enGene Holdings Inc.
CIK 0001980845
Entity typeother
Related Parties
1- filerCIK 0001998684
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:42 PM ET
- Size
- 6.7 KB